Tower Research Capital (TRC)’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,107
Closed -$80K 6069
2020
Q4
$80K Sell
1,107
-25,629
-96% -$1.34M ﹤0.01% 2573
2020
Q3
$1.22M Buy
26,736
+23,152
+646% +$968K 0.01% 794
2020
Q2
$162K Buy
+3,584
New +$161K 0.01% 1999
2019
Q4
Sell
-606
Closed -$25K 4904
2019
Q3
$25K Sell
606
-424
-41% -$18.3K ﹤0.01% 2329
2019
Q2
$50K Buy
+1,030
New +$54.1K ﹤0.01% 1580
2018
Q4
Sell
-264
Closed -$17K 4791
2018
Q3
$17K Buy
+264
New +$14.7K ﹤0.01% 2470
2018
Q2
Sell
-3,351
Closed -$104K 4450
2018
Q1
$104K Buy
+3,351
New +$110K 0.01% 1238
2017
Q4
Sell
-4,820
Closed -$159K 4478
2017
Q3
$159K Buy
4,820
+4,446
+1,189% +$154K 0.01% 948
2017
Q2
$13K Buy
+374
New +$11.2K ﹤0.01% 1484
2017
Q1
Sell
-209
Closed -$5K 4599
2016
Q4
$5K Sell
209
-929
-82% -$18.2K ﹤0.01% 3113
2016
Q3
$22K Buy
+1,138
New +$21.5K ﹤0.01% 1564
2016
Q1
Sell
-832
Closed -$10K 5718
2015
Q4
$10K Buy
832
+308
+59% +$3.9K ﹤0.01% 2216
2015
Q3
$6K Buy
+524
New +$6.68K ﹤0.01% 2751
2015
Q2
Sell
-4,190
Closed -$37K 5670
2015
Q1
$37K Buy
4,190
+3,380
+417% +$34.1K ﹤0.01% 1744
2014
Q4
$8K Sell
810
-422
-34% -$3.62K ﹤0.01% 2402
2014
Q3
$8K Sell
1,232
-12,515
-91% -$87.8K ﹤0.01% 3046
2014
Q2
$98K Buy
13,747
+13,364
+3,489% +$106K 0.01% 923
2014
Q1
$3K Sell
383
-9,542
-96% -$87.8K ﹤0.01% 3792
2013
Q4
$79K Buy
9,925
+7,614
+329% +$71.1K 0.01% 1002
2013
Q3
$22K Buy
2,311
+2,151
+1,344% +$16.9K ﹤0.01% 2628
2013
Q2
$1K Buy
+160
New +$538 ﹤0.01% 3869

Other funds holding BEAT

Tower Research Capital (TRC)'s BEAT Position: Q1 2021 in Review

Tower Research Capital (TRC) sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 1,107 shares — an estimated $80K sold.

Tower Research Capital (TRC) first reported a position in BEAT in Q2 2013 and held it in 21 quarters. The position peaked at $1.22M in Q3 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Tower Research Capital (TRC) reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,107 BioTelemetry, Inc. shares in Q1 2021, an estimated $80K.
  • Tower Research Capital (TRC) first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 21 quarters.
  • Tower Research Capital (TRC)'s BioTelemetry, Inc. position peaked at $1.22M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.